Autoantigen diversity in the opsoclonus-myoclonus syndrome

被引:98
|
作者
Bataller, L
Rosenfeld, MR
Graus, F
Vilchez, JJ
Cheung, NKV
Dalmau, J
机构
[1] Hosp Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA
[2] Univ Arkansas Med Sci, Dept Neurol, Little Rock, AR 72205 USA
[3] Univ Arkansas Med Sci, Dept Microbiol & Immunol, Little Rock, AR 72205 USA
[4] Cent Arkansas Vet Hlth Care Syst, Little Rock, AR USA
[5] Univ Barcelona, Hosp Clin, Dept Neurol, Barcelona, Spain
[6] Univ Barcelona, Inst Invest Biomed August Pi i Sunyer, Hosp Clin, Barcelona, Spain
[7] Univ Hosp La Fe, Dept Neurol, Valencia, Spain
[8] Mem Sloan Kettering Canc Ctr, Dept Pediat, New York, NY 10021 USA
关键词
D O I
10.1002/ana.10462
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Despite circumstantial evidence that opsoclonus-myoclonus (OM) is often immune mediated, no specific autoantigen has been identified. Using sera of 21 patients with several types of OM (idiopathic, associated to small cell lung cancer, and associated to neuroblastoma), we probed a brainstem cDNA library to isolate target neuronal antigens. Thirty-seven clones coding for 25 proteins were isolated, with two groups of autoantigens emerging: (1) proteins of the postsynaptic density, among them the adenomatous polyposis coli, and (2) proteins with expression or function restricted to neurons, including RNA or DNA-binding proteins and zinc-finger proteins. Usually, each patient's serum recognized a different autoantigen, except for adenomatous polyposis coli that was recognized by sera of two patients with idiopathic OM and two control patients with nystagmus, diplopia, and paraneoplastic brainstem dysfunction. Overall, in the indicated types of OM, (1) we found frequent and heterogeneous immunity to neuronal autoantigens without a single specific antibody marker of OM, (2) the occasional detection of antibodies to known onconeuronal antigens (ie, Hu proteins) probably is related to cancer-induced immunity rather than to OM, and (3) the postsynaptic density is a frequent source of novel autoantigens, with several proteins of this complex targeted by antibodies of OM patients.
引用
收藏
页码:347 / 353
页数:7
相关论文
共 50 条
  • [1] Opsoclonus-myoclonus syndrome
    Arroyo, Hugo A.
    Tringler, Natalia
    Santos, Cecilia de los
    MEDICINA-BUENOS AIRES, 2009, 69 (01) : 64 - 70
  • [2] Opsoclonus-myoclonus syndrome
    Blaes, F.
    JOURNAL OF NEURAL TRANSMISSION, 2007, 114 (07) : CVI - CVI
  • [3] THE SYNDROME OF OPSOCLONUS-MYOCLONUS
    LEOPOLD, HC
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 1985, 53 (02) : 42 - 54
  • [4] The opsoclonus-myoclonus syndrome
    De Broucker, T
    Zuber, A
    REVUE NEUROLOGIQUE, 2000, 156 (01) : 73 - 75
  • [5] The immunopharmacology of the opsoclonus-myoclonus syndrome
    Pranzatelli, MR
    CLINICAL NEUROPHARMACOLOGY, 1996, 19 (01) : 1 - 47
  • [6] Opsoclonus-myoclonus syndrome in children
    Petrukhin, A. S.
    Bembeeva, R. Ts.
    Samoilova, M. V.
    ZHURNAL NEVROLOGII I PSIKHIATRII IMENI S S KORSAKOVA, 2006, 106 (02): : 63 - 66
  • [7] Opsoclonus-myoclonus syndrome in children
    Iljina, E.
    Bobylova, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2009, 16 : 172 - 172
  • [8] Opsoclonus-myoclonus syndrome in adults
    McKeon, A.
    Klaas, J.
    MOVEMENT DISORDERS, 2012, 27 : S200 - S200
  • [9] Opsoclonus-Myoclonus syndrome in adults
    Bonnet, L.
    de Bustos, E. Medeiros
    Moulin, T.
    REVUE NEUROLOGIQUE, 2012, 168 (12) : 987 - 988
  • [10] THE NEUROBIOLOGY OF THE OPSOCLONUS-MYOCLONUS SYNDROME
    PRANZATELLI, MR
    CLINICAL NEUROPHARMACOLOGY, 1992, 15 (03) : 186 - 228